TD1.AX TALi Digital (ASX) down 16.67% intraday 21 Mar 2026: A$0.04 outlook

TD1.AX stock plunged 16.67% intraday to A$0.04 on 21 Mar 2026 as sellers accelerated after an earlier A$0.045 open. The move makes TALi Digital Limited (TD1.AX) one of today’s top losers on the ASX, trading 67,918 shares versus a 30‑day average of 98,635. Intraday weakness follows stretched multi‑month declines and renewed liquidity concerns in this small‑cap healthcare name.

TD1.AX stock intraday price action and liquidity

TD1.AX stock fell from a previous close of A$0.05 to A$0.04, with a session low of A$0.04 and high of A$0.045 on 21 Mar 2026. Volume reached 67,918 shares, about 0.18 times average volume, signalling limited liquidity and sharper moves on small orders.

Traders should note the year high is A$0.20 and year low is A$0.04, which highlights significant downside over 12 months and higher intraday volatility on the ASX in AUD.

Drivers: earnings, licensing news and sector context

TD1.AX earnings show EPS of -0.02 and a negative PE of -2.00, reflecting continued losses and early commercial scale. The company’s strategic licensing agreement with Akili Interactive remains material, but revenue momentum is weak and investors reacted to slower uptake in digital health sales.

Healthcare sector breadth is under pressure, with the ASX healthcare group showing a YTD decline. That sector weakness likely amplified selling in this small healthcare technology stock.

Financials and valuation metrics for TALi Digital Limited

Market cap for TALi Digital Limited (TD1.AX) sits at A$1,869,099 with 46,727,478 shares outstanding. Key ratios show a price to book of 0.79, price to sales of 27.48, current ratio 3.23, and cash per share A$0.03. These figures point to a solid liquidity cushion but low revenue scale and negative margins.

Receivables days are stretched at 524.59 days and free cash flow per share is -0.02, which increases operational risk and potential financing needs for growth.

Meyka AI rates TD1.AX with a score out of 100 and technicals

Meyka AI rates TD1.AX with a score out of 100: 67.93 which translates to a B grade and a HOLD suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and are for informational use only.

Technicals show TD1.AX is oversold with RSI 23.85 and CCI -247.06, while Bollinger bands sit at 0.04/0.05/0.06 (lower/mid/upper). The short‑term momentum readings signal downside risk but also potential mean‑reversion opportunities for active traders.

Meyka AI’s forecast model projects price targets and implied moves

Meyka AI’s forecast model projects monthly A$0.05, quarterly A$0.07, and yearly A$0.066385 prices for TD1.AX stock. Compared with the current price of A$0.04, that implies a monthly upside of 25.00%, a quarterly upside of 75.00%, and a 12‑month upside of 66.00%.

Forecasts are model‑based projections and not guarantees. Given thin trading and negative margins, variance around these targets can be large and risk of dilution remains material.

Trading note: liquidity, risk management and top losers strategy

As a top loser on the ASX intraday list, TD1.AX carries high volatility and low liquidity. A conservative short‑term price target is A$0.05, while a tactical recovery target sits at A$0.07 if uptake improves. A downside support level to watch is A$0.03 on heavy selling.

For ASX traders, limit orders, position sizing and liquidity checks matter. See the company profile and competitor compare for context on market positioning source. For an internal view, review the TD1.AX page on Meyka’s platform TD1.AX stock page.

Final Thoughts

TD1.AX stock fell 16.67% intraday to A$0.04 on 21 Mar 2026, driven by thin liquidity, continued losses and weak revenue scale. Meyka AI’s forecast model projects a 12‑month price of A$0.066385, implying about 66.00% upside versus today’s price. Our Meyka grade (B, HOLD) reflects mixed signals: strong liquidity ratios but negative earnings and long receivable days. Short‑term traders should expect high volatility and use tight risk controls. Long‑term investors must watch revenue pick‑up, Akili licensing progress, and any capital raises that could dilute value. Forecasts are model‑based projections and not guarantees. Reassess if TD1.AX posts improved quarterly revenue or narrower receivables days.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.